Please enable JavaScript to continue using this application.

Compare $KURA vs $ODTX | Chartloom

Compare

$KURA vs $ODTX

Kura Oncology Inc · Odyssey Therapeutics Inc

KURA

Kura Oncology Inc

ODTX

Odyssey Therapeutics Inc

Compare $KURA vs $ODTX

Comparing Kura Oncology Inc and Odyssey Therapeutics Inc

KURAKura Oncology Inc

ODTXOdyssey Therapeutics Inc

KURAKura Oncology Inc

Market cap

$941M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

6.49x

Rev growth (TTM)

-7.3%

YTD performance

2.6%

52W performance

5.2%

FCF yield

-12.5%

ODTXOdyssey Therapeutics Inc

Market cap

$913M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-19.0%

YTD performance

15.7%

52W performance

15.7%

FCF yield

-4.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KURA

ODTX

Detailed metrics comparison

KURA

Kura Oncology Inc

ODTX

Odyssey Therapeutics Inc

Market Cap

KURA$941M

ODTX$913M

Enterprise Value

KURA$881M

ODTX$831M

Price

KURA$10.60

ODTX$19.00

P/E Ratio

KURAN/A

ODTXN/A

P/S Ratio

KURA12.18x

ODTX306.64x

EV/Sales

KURA11.40x

ODTX279.08x

EV/EBITDA

KURA0.00x

ODTX0.00x

P/B Ratio

KURA19.56x

ODTX2.36x

P/FCF Ratio

KURAN/A

ODTXN/A

EV/FCF

KURA-7.50x

ODTX-21.89x

PEG Ratio

KURAN/A

ODTXN/A

Forward P/E (NTM)

KURAN/A

ODTXN/A

Forward P/S (NTM)

KURA6.49x

ODTXN/A

Revenue (TTM)

KURA$77M

ODTX$3M

Revenue Growth (YoY)

KURA-7.3%

ODTX-19.0%

Forward Rev Growth

KURA106.3%

ODTX410.3%

Gross Margin (TTM)

KURA72.4%

ODTX0.0%

Operating Margin (TTM)

KURA0.0%

ODTX0.0%

EBITDA Margin (TTM)

KURA-410.2%

ODTX-3193.4%

Net Margin (TTM)

KURA-384.3%

ODTX-8054.3%

FCF Margin (TTM)

KURA-152.1%

ODTX-1275.0%

Net Income (TTM)

KURA$-297M

ODTX$-240M

FCF (TTM)

KURA$-117M

ODTX$-38M

EPS (TTM)

KURA-$3.34

ODTX-$7.92

ROE (TTM)

KURA-20718.0%

ODTX-3030.0%

ROA (TTM)

KURA-4517.0%

ODTX-2554.0%

ROIC (TTM)

KURA-19400.0%

ODTX-3030.0%

Cash

KURA$70M

ODTX$82M

Debt

KURA$10M

ODTX$0

Net Cash/Debt

KURA$60M

ODTX$82M

Current Ratio (TTM)

KURA4.73x

ODTX11.36x

Quick Ratio (TTM)

KURA4.47x

ODTX10.98x

Debt/Equity (TTM)

KURA0.20x

ODTX0.00x

Debt/Assets (TTM)

KURA0.0%

ODTX0.0%

Interest Coverage (TTM)

KURAN/A

ODTXN/A

Net Debt/EBITDA (TTM)

KURA0.00x

ODTX0.00x

Beta

KURA0.53

ODTX-0.23

52W Performance

KURA5.2%

ODTX15.7%

YTD Performance

KURA2.6%

ODTX15.7%

% from 52W High

KURA-23.7%

ODTX-34.6%

% from 52W Low

KURA44.1%

ODTX25.8%

Asset Turnover (TTM)

KURA0.12x

ODTX0.00x

FCF Yield (TTM)

KURA-12.5%

ODTX-4.2%

Earnings Yield (TTM)

KURA-31.5%

ODTX-26.3%

Dividend Yield (TTM)

KURAN/A

ODTXN/A

Rule of 40

KURA-159.3

ODTX-1,294.1

EV/GP/RG

KURA0.09

ODTXN/A

Ticker research

View KURA research View ODTX research

Metric	KURA Kura Oncology Inc	ODTX Odyssey Therapeutics Inc
Market & Valuation
Market Cap	$941M	$913M
Enterprise Value	$881M	$831M
Price	$10.60	$19.00
P/E Ratio	N/A	N/A
P/S Ratio	12.18x	306.64x
EV/Sales	11.40x	279.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.56x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-21.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.49x	N/A
Revenue & Growth
Revenue (TTM)	$77M	$3M
Revenue Growth (YoY)	-7.3%	-19.0%
Forward Rev Growth	106.3%	410.3%
Profitability
Gross Margin (TTM)	72.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-410.2%	-3193.4%
Net Margin (TTM)	-384.3%	-8054.3%
FCF Margin (TTM)	-152.1%	-1275.0%
Net Income (TTM)	$-297M	$-240M
FCF (TTM)	$-117M	$-38M
EPS (TTM)	-$3.34	-$7.92
ROE (TTM)	-20718.0%	-3030.0%
ROA (TTM)	-4517.0%	-2554.0%
ROIC (TTM)	-19400.0%	-3030.0%
Financial Health
Cash	$70M	$82M
Debt	$10M	$0
Net Cash/Debt	$60M	$82M
Current Ratio (TTM)	4.73x	11.36x
Quick Ratio (TTM)	4.47x	10.98x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.53	-0.23
52W Performance	5.2%	15.7%
YTD Performance	2.6%	15.7%
% from 52W High	-23.7%	-34.6%
% from 52W Low	44.1%	25.8%
Efficiency & Yields
Asset Turnover (TTM)	0.12x	0.00x
FCF Yield (TTM)	-12.5%	-4.2%
Earnings Yield (TTM)	-31.5%	-26.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-159.3	-1,294.1
EV/GP/RG	0.09	N/A
Ticker research	View KURA research	View ODTX research

Valuation

P/S Ratio

KURA

12.18x

ODTX

306.64x

EV/FCF

ODTX

-21.89x

KURA

-7.50x

Growth & revenue

Revenue Growth TTM

KURA

-7.3%

ODTX

-19.0%

Forward Revenue Growth

ODTX

410.3%

KURA

106.3%

Profitability & performance

Gross Margin

KURA

72.4%

ODTX

0.0%

ROE

ODTX

-3030.0%

KURA

-20718.0%

FCF Yield %

ODTX

-4.2%

KURA

-12.5%

52-Week Performance

ODTX

15.7%

KURA

5.2%

Detailed metrics comparison

KURA

Kura Oncology Inc

ODTX

Odyssey Therapeutics Inc

Market Cap

KURA$941M

ODTX$913M

Enterprise Value

KURA$881M

ODTX$831M

Price

KURA$10.60

ODTX$19.00

P/E Ratio

KURAN/A

ODTXN/A

P/S Ratio

KURA12.18x

ODTX306.64x

EV/Sales

KURA11.40x

ODTX279.08x

EV/EBITDA

KURA0.00x

ODTX0.00x

P/B Ratio

KURA19.56x

ODTX2.36x

P/FCF Ratio

KURAN/A

ODTXN/A

EV/FCF

KURA-7.50x

ODTX-21.89x

PEG Ratio

KURAN/A

ODTXN/A

Forward P/E (NTM)

KURAN/A

ODTXN/A

Forward P/S (NTM)

KURA6.49x

ODTXN/A

Revenue (TTM)

KURA$77M

ODTX$3M

Revenue Growth (YoY)

KURA-7.3%

ODTX-19.0%

Forward Rev Growth

KURA106.3%

ODTX410.3%

Gross Margin (TTM)

KURA72.4%

ODTX0.0%

Operating Margin (TTM)

KURA0.0%

ODTX0.0%

EBITDA Margin (TTM)

KURA-410.2%

ODTX-3193.4%

Net Margin (TTM)

KURA-384.3%

ODTX-8054.3%

FCF Margin (TTM)

KURA-152.1%

ODTX-1275.0%

Net Income (TTM)

KURA$-297M

ODTX$-240M

FCF (TTM)

KURA$-117M

ODTX$-38M

EPS (TTM)

KURA-$3.34

ODTX-$7.92

ROE (TTM)

KURA-20718.0%

ODTX-3030.0%

ROA (TTM)

KURA-4517.0%

ODTX-2554.0%

ROIC (TTM)

KURA-19400.0%

ODTX-3030.0%

Cash

KURA$70M

ODTX$82M

Debt

KURA$10M

ODTX$0

Net Cash/Debt

KURA$60M

ODTX$82M

Current Ratio (TTM)

KURA4.73x

ODTX11.36x

Quick Ratio (TTM)

KURA4.47x

ODTX10.98x

Debt/Equity (TTM)

KURA0.20x

ODTX0.00x

Debt/Assets (TTM)

KURA0.0%

ODTX0.0%

Interest Coverage (TTM)

KURAN/A

ODTXN/A

Net Debt/EBITDA (TTM)

KURA0.00x

ODTX0.00x

Beta

KURA0.53

ODTX-0.23

52W Performance

KURA5.2%

ODTX15.7%

YTD Performance

KURA2.6%

ODTX15.7%

% from 52W High

KURA-23.7%

ODTX-34.6%

% from 52W Low

KURA44.1%

ODTX25.8%

Asset Turnover (TTM)

KURA0.12x

ODTX0.00x

FCF Yield (TTM)

KURA-12.5%

ODTX-4.2%

Earnings Yield (TTM)

KURA-31.5%

ODTX-26.3%

Dividend Yield (TTM)

KURAN/A

ODTXN/A

Rule of 40

KURA-159.3

ODTX-1,294.1

EV/GP/RG

KURA0.09

ODTXN/A

Ticker research

View KURA research View ODTX research

Metric	KURA Kura Oncology Inc	ODTX Odyssey Therapeutics Inc
Market & Valuation
Market Cap	$941M	$913M
Enterprise Value	$881M	$831M
Price	$10.60	$19.00
P/E Ratio	N/A	N/A
P/S Ratio	12.18x	306.64x
EV/Sales	11.40x	279.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	19.56x	2.36x
P/FCF Ratio	N/A	N/A
EV/FCF	-7.50x	-21.89x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	6.49x	N/A
Revenue & Growth
Revenue (TTM)	$77M	$3M
Revenue Growth (YoY)	-7.3%	-19.0%
Forward Rev Growth	106.3%	410.3%
Profitability
Gross Margin (TTM)	72.4%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-410.2%	-3193.4%
Net Margin (TTM)	-384.3%	-8054.3%
FCF Margin (TTM)	-152.1%	-1275.0%
Net Income (TTM)	$-297M	$-240M
FCF (TTM)	$-117M	$-38M
EPS (TTM)	-$3.34	-$7.92
ROE (TTM)	-20718.0%	-3030.0%
ROA (TTM)	-4517.0%	-2554.0%
ROIC (TTM)	-19400.0%	-3030.0%
Financial Health
Cash	$70M	$82M
Debt	$10M	$0
Net Cash/Debt	$60M	$82M
Current Ratio (TTM)	4.73x	11.36x
Quick Ratio (TTM)	4.47x	10.98x
Debt/Equity (TTM)	0.20x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.53	-0.23
52W Performance	5.2%	15.7%
YTD Performance	2.6%	15.7%
% from 52W High	-23.7%	-34.6%
% from 52W Low	44.1%	25.8%
Efficiency & Yields
Asset Turnover (TTM)	0.12x	0.00x
FCF Yield (TTM)	-12.5%	-4.2%
Earnings Yield (TTM)	-31.5%	-26.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-159.3	-1,294.1
EV/GP/RG	0.09	N/A
Ticker research	View KURA research	View ODTX research